PHOENIX allografts consist of allogenic bone. They offer the properties of micro and macroporosity natural physiological human cancellous bone.
They consist of mineralized bone, delipidized, allowing immediate colonization of patient cells and vessels for rapid osseointegration.
These qualities were demonstrated by TBF in a multicentric study, were confirmed by various studies and scientific publications (see Bibliography section), and above all demonstrated by the users through the grafts clinical efficacy since 1994.
Scientific studies published in JBJS (Journal of Bone & Joint Surgery) and EJOST (European Journal of Orthopaedic Surgery and Traumatology) for surgeries of hip revisions with PHOENIX products show a fast osseointegration with rates of 94 to 100%.